pharma · MASH · MASLD · SGMT
Sagimet Biosciences
Sagimet Biosciences is a pharma organization headquartered in San Mateo, USA. It trades on NYSE under ticker SGMT. Primary therapeutic focus areas include MASH, MASLD, Metabolic Syndrome, Non-alcoholic Steatohepatitis, K
Company details
- Status
- Public
- HQ
- 155 Bovet Rd, Suite 303, San Mateo, California 94402, US
- Employees
- 27
- Programs
- 12
- Drugs
- 4
- Patents
- 1
Quick answer
Sagimet Biosciences is a pharma organization headquartered in San Mateo, USA. It trades on NYSE under ticker SGMT. Primary therapeutic focus areas include MASH, MASLD, Metabolic Syndrome, Non-alcoholic Steatohepatitis, KRAS Gene Mutation. NovaPharmaNews links 12 clinical program(s), 0 drug profile(s), and 1 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (6), phase 2 (4), phase 3 (2).
Company snapshot
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a platform of proprietary FASN inhibitors. For more information, please visit www.sagimet
- 12 active pipeline program(s) linked via ClinicalTrials.gov.
- 1 US patent(s) indexed to this assignee profile.
- 12 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Sagimet Biosciences. Not investment advice.
Top assets
Lead pipeline drugs
- approved
- approved
- Marketed / approved
- approved
Active clinical programs
- Phase 3
- Phase 3
- Phase 2
- Phase 2
Momentum
Proprietary activity score for Sagimet Biosciences.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Recent activity
Latest pipeline, patent, and corporate events for Sagimet Biosciences.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Sagimet Biosciences?
-
Is Sagimet Biosciences publicly traded?
-
What drugs does Sagimet Biosciences develop or market?
-
What are the latest developments for Sagimet Biosciences?
-
What therapeutic areas does Sagimet Biosciences focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.